B+
Bull case
25%
Probability
Target price
$2.20
Analysis reference price unavailable
Analysis 2026-04-30 · RankAlpha Sentiment Codex
CBUS
CibusDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
The best-supported positives are continued rice-program progress, defined 2026 partner milestones, a targeted 2027/2028 rice launch path, and cost actions intended to extend cash runway [#PR-2026-03-17].
Posture
Defensive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite.
What can break
Additional financing may still be needed if commercialization or partnering slips beyond management's current runway window.
Momentum
100
Value
41
Sentiment
42
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $1.30 · Bull $2.20 · Bear $0.60Analysis 2026-04-30; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-09 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-30 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-09
Investment thesis
As of 2026-09-09
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-09. Definitions
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $14.33
Why
Momentum100 · Δ7d -
Value41 · Δ7d 0.0
Sentiment42 · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Confirming evidence
- • Sentiment remains the lead driver in the composite.
Contradictions & invalidation
- • Additional financing may still be needed if commercialization or partnering slips beyond management's current runway window.
- • Rice commercialization evidence is still mostly milestone and partner-progress based rather than proven recurring royalty revenue.
- • The main negatives are that Cibus is still pre-scale commercially, has limited external coverage, continues to evaluate strategic alternatives, and faces financing or dilution risk if partner conversion and commercialization timelines slip.
Catalyst clock
2026-09-30
Runway and financing overhang remains the nearest-term issue
Lead driver: Sentiment · See AI snapshot
Momentum
100
9% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
41
28% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
+0.1
Sentiment
42
62% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade D. Momentum 99.5 / Value 41.2 / Sentiment 42.2
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-04-30. Scenario method
Most likely
B
Base case
45%
Probability
Target price
$1.30
Analysis reference price unavailable
Analysis 2026-04-30 · RankAlpha Sentiment Codex
B-
Bear case
30%
Probability
Target price
$0.60
Analysis reference price unavailable
Analysis 2026-04-30 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$127.47M
Beta
1.80
Shares Out
76.33M
P/E (TTM) · Derived
-0.6
P/S (TTM)
28.90
P/FCF (TTM) · Derived
-2.15
Rev YoY
+6.5%
EPS YoY
-52.7%
Gross Margin
-18.0%
Op Margin
-1240.9%
Net Debt
$258.04M
Current Ratio
1.62
As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data